Source-grounded facts extracted from BONK, INC.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Brian John was appointed as Chief Executive Officer at BONK, INC..
“On May 1, 2023, the board of directors (the “Board”) of Jupiter Wellness, Inc. (the “Company”) re-appointed Brian John as the Chief Executive Officer of the Company for a guaranteed two-year term with auto extension/renewal.”
BONK, INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).
“March 3, 2023, Jupiter Wellness, Inc. (the “Company”) received a deficiency letter (the “Notice”) from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, based upon the closing bid price of the Company’s common stock (“Common Stock”) for the last 30 consecutive business days, the Company is not currently in compliance with the requirement to maintain a minimum bid price of $1.00 per share for continued listing on the Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Requirement”). The Notice has no i”
Dr. Hector Alila was appointed as Director at BONK, INC..
“On February 1, 2023, Jupiter Wellness, Inc. (the “Company”) appointed Dr. Hector Alila as an additional director .”
BONK, INC. entered into Registration Rights Agreement with the Purchasers (effective 2023-01-19).
“On January 19, 2023, the Company also entered into a Registration Rights Agreement with the Purchasers, (the "Registration Rights Agreement" and together with the PIPE Agreement and the RD Agreement the "Agreements"), requiring the Company to register the securities issued under the PIPE Agreement”
BONK, INC. entered into RD Agreement with certain purchasers (effective 2023-01-19).
“On January 19, 2023, The Company entered into a Securities Purchase Agreement (the "RD Agreement") with certain purchasers, pursuant to which on January 23, 2023, 4,315,787 shares of common stock, par value $0.001 (the "Common Stock"), at a price of $0.70 per share were issued to the purchasers (the "RD Offering")”
BONK, INC. entered into PIPE Agreement with certain purchasers (effective 2023-01-19).
“On January 19, 2023, Jupiter Wellness, Inc., (the "Company") entered into a Securities Purchase Agreement (the "PIPE Agreement") with certain purchasers, for the issuance of 8,631,574 common stock warrants (the "PIPE Offering") at a price of $0.125 per warrant”
BONK, INC. shareholders approved Approval of potential issuance of securities at a discounted price under non-public offerings at the 2022-12-22 meeting.
“7. The Company’s stockholders approved the potential issuance of securities at a discounted price under non-public offerings. The number of shares that voted for, against, and withheld from voting for this proposal is summarized in the table below: Votes Withheld 7,395,435 604,268 24,772”
BONK, INC. shareholders approved Approval and ratification of 2022 Equity Incentive Plan at the 2022-12-22 meeting.
“6. The Company’s stockholders approved and ratified the Company’s 2022 Equity Incentive Plan. The number of shares that voted for, against, and withheld from voting for this proposal is summarized in the table below: Votes Withheld 7,396,668 605,036 22,771”
BONK, INC. shareholders approved Approval of amendment to Certificate of Incorporation to effect reverse stock split at the 2022-12-22 meeting.
“5. The Company’s stockholders approved the amendment to the Company’s Certificate of Incorporation to effect reverse stock split. The number of shares that voted for, against, and withheld from voting for this proposal is summarized in the table below: Votes Withheld 11,367,174 1,659,489 25,843”
BONK, INC. shareholders approved Ratification of M&K CPAS, PLLC as independent auditor at the 2022-12-22 meeting.
“4. The Company’s stockholders ratified the appointment of M&K CPAS, PLLC as the independent registered public accounting firm of the Company for the fiscal year ending June 30, 2023. The number of shares that voted for, against, and withheld from voting for this proposal is summarized in the table below: Votes Withheld 12,989,861 51,700 10,945”
BONK, INC. shareholders approved Non-binding advisory vote on frequency of future advisory votes on executive compensation at the 2022-12-22 meeting.
“3. The Company’s stockholders recommend, on a non-binding advisory basis, the frequency of future advisory votes on the compensation of the Company’s named executive officers. The number of shares that voted for this proposal is summarized in the table below: One Year Two Year Three Year Abstain 2,451,600 32,220 5,507,138 33,517”
BONK, INC. shareholders approved Advisory vote on compensation of named executive officers at the 2022-12-22 meeting.
“2. The Company’s stockholder held an advisory vote on the compensation of the named executive officers. The number of shares that voted for, against, and withheld from voting for this proposal is summarized in the table below: Votes Withheld 7,967,845 35,550 21,080”
BONK, INC. shareholders approved Election of six directors at the 2022-12-22 meeting.
“Director Nominee Votes For Votes Against Votes Withheld Brian S. John 7,987,891 28,587 7,997 Dr. Glynn Wilson 7,998,464 18,154 7,857 Dr. Skender Fani 7,996,117 22,025 6,333 Nancy Torres Kaufman 7,997,481 20,232 6,762 Christopher Marc Melton 7,897,446 119,266 7,763 Gary Herman 7,994,827 21,646 8,002”
BONK, INC. entered into Distribution Agreement with Ardis Enterprises LLC (effective 2022-12-01).
“On December 1, 2022 (the “Effective Date”), Jupiter Wellness, Inc. (the “Company”) entered into a distribution agreement (the “Distribution Agreement”) with Ardis Enterprises LLC, a Florida corporation (“Distributor”), pursuant to which the Company appointed Distributor the exclusive authorized distributor of the Company’s CaniSun and No Stingz sunscreens within the state of Florida.”
BONK, INC. received a nasdaq compliance regained notice regarding minimum bid price (rules 5550(a)(2)).
“previously reported, on June 23, 2022, Jupiter Wellness Inc. (the “Company”) received a notice (the “Notice”) from the staff of the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it was not in compliance with Nasdaq Listing Rule 5550(a)(2) (the “Rule”) because it failed to maintain a minimum bid price of $1.00 over the previous 30 consecutive business days. Since then, the Staff has determined that for the last 10 consecutive business days, from November 4, 2022, to November 17, 2022, the closing bid price of the Company’s”
Dr. Hector Alila departed as director at BONK, INC..
“Dr. Fani will replace Dr. Hector Alila, who will be moving to the Company’s Scientific Advisory Board.”
Dr. Skender Fani was appointed as director at BONK, INC..
“On September 9, 2022, the Board of Directors of Jupiter Wellness, Inc. (the “Company”) announced the appointment of Dr. Skender Fani as a director of the Company, effective September 15, 2022.”
Ryan Allison resigned as Chief Operating Officer at BONK, INC..
“On March 4, 2022, Ryan Allison, Chief Operating Officer of Jupiter Wellness, Inc., a Delaware corporation (the “Company”), resigned by mutual agreement from such position effective immediately (the “Resignation Date”).”
Gary Herman was appointed as member of the Board at BONK, INC..
“On March 1, 2022, the Board appointed Gary Herman to serve as a member of the Board.”
Byron Young resigned as member of the Board of Directors at BONK, INC..
“On February 23, 2022, Byron Young resigned as a member of the Board of Directors (the “Board”) of Jupiter Wellness, Inc. (the “Company”) for personal reasons.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.